Vectus Biosystems: Could this drug eventually prevent thousands of deaths?
Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.

Beetaloo Energy: Could this Aussie onshore basin have 200 years of gas in it?
03:04

Rio2 Ltd: Its gold, gold, gold for Rio2 …. and copper
02:25

Heavy Minerals Ltd: From trash to treasure; making industrial garnets from copper tailings
02:33